Size-dependent specific targeting and efficient gene silencing in peritoneal macrophages using a pH-sensitive cationic liposomal siRNA carrier.

[1]  E. Chargaff,et al.  Nucleic Acids , 2020, Definitions.

[2]  L. Pirdel,et al.  Role of iron overload-induced macrophage apoptosis in the pathogenesis of peritoneal endometriosis. , 2014, Reproduction.

[3]  R. Medzhitov,et al.  Tissue-Specific Signals Control Reversible Program of Localization and Functional Polarization of Macrophages , 2014, Cell.

[4]  Y. Hirata,et al.  In vivo therapeutic potential of Dicer-hunting siRNAs targeting infectious hepatitis C virus. , 2014, Scientific Reports.

[5]  N. Kaji,et al.  Hepatic Monoacylglycerol O-acyltransferase 1 as a Promising Therapeutic Target for Steatosis, Obesity, and Type 2 Diabetes , 2014, Molecular therapy. Nucleic acids.

[6]  H. Naora.  Heterotypic Cellular Interactions in the Ovarian Tumor Microenvironment: Biological Significance and Therapeutic Implications , 2014, Front. Oncol..

[7]  Akin Akinc,et al.  Influence of Polyethylene Glycol Lipid Desorption Rates on Pharmacokinetics and Pharmacodynamics of siRNA Lipid Nanoparticles , 2013, Molecular therapy. Nucleic acids.

[8]  Lichen Yin,et al.  Trimethyl Chitosan-Cysteine Nanoparticles for Systemic Delivery of TNF-α siRNA via Oral and Intraperitoneal Routes , 2013, Pharmaceutical Research.

[9]  Alan McLachlan,et al.  Hepatocyte-targeted RNAi Therapeutics for the Treatment of Chronic Hepatitis B Virus Infection , 2013, Molecular therapy : the journal of the American Society of Gene Therapy.

[10]  H. Harashima,et al.  A pH-sensitive cationic lipid facilitates the delivery of liposomal siRNA and gene silencing activity in vitro and in vivo. , 2012, Journal of controlled release : official journal of the Controlled Release Society.

[11]  D. Peter Tieleman,et al.  Lipid Nanoparticles Containing siRNA Synthesized by Microfluidic Mixing Exhibit an Electron-Dense Nanostructured Core , 2012, The journal of physical chemistry. C, Nanomaterials and interfaces.

[12]  Shigeo Matsuda,et al.  Maximizing the Potency of siRNA Lipid Nanoparticles for Hepatic Gene Silencing In Vivo** , 2012, Angewandte Chemie.

[13]  M. Behlke,et al.  Protection against TNFα-dependent liver toxicity by intraperitoneal liposome delivered DsiRNA targeting TNFα in vivo. , 2012, Journal of controlled release : official journal of the Controlled Release Society.

[14]  Daniel G. Anderson,et al.  Systemic RNAi-mediated Gene Silencing in Nonhuman Primate and Rodent Myeloid Cells , 2012, Molecular therapy. Nucleic acids.

[15]  A. Singhania,et al.  Effective Delivery of PEGylated siRNA-Containing Lipoplexes to Extraperitoneal Tumours following Intraperitoneal Administration , 2011, Journal of drug delivery.

[16]  Mark E. Davis,et al.  Evidence of RNAi in humans from systemically administered siRNA via targeted nanoparticles , 2010, Nature.

[17]  D. Peer,et al.  RNAi-mediated CCR5 silencing by LFA-1-targeted nanoparticles prevents HIV infection in BLT mice. , 2010, Molecular therapy : the journal of the American Society of Gene Therapy.

[18]  K. G. Rajeev,et al.  Rational design of cationic lipids for siRNA delivery , 2010, Nature Biotechnology.

[19]  Leonore A. Herzenberg,et al.  Two physically, functionally, and developmentally distinct peritoneal macrophage subsets , 2010, Proceedings of the National Academy of Sciences.

[20]  Kathryn A. Whitehead,et al.  Lipid-like materials for low-dose, in vivo gene silencing , 2010, Proceedings of the National Academy of Sciences.

[21]  Michael S. Goldberg,et al.  Drug Delivery–mediated Control of RNA Immunostimulation , 2009, Molecular Therapy.

[22]  A. Judge,et al.  Confirming the RNAi-mediated mechanism of action of siRNA-based cancer therapeutics in mice. , 2009, The Journal of clinical investigation.

[23]  A. Judge,et al.  Misinterpreting the therapeutic effects of small interfering RNA caused by immune stimulation. , 2008, Human gene therapy.

[24]  D. Peer,et al.  Systemic Leukocyte-Directed siRNA Delivery Revealing Cyclin D1 as an Anti-Inflammatory Target , 2008, Science.

[25]  B. Davidson,et al.  Transvascular delivery of small interfering RNA to the central nervous system , 2007, Nature.

[26]  Matthias John,et al.  RNAi-mediated gene silencing in non-human primates , 2006, Nature.

[27]  P. Sugarbaker,et al.  Pharmacokinetic changes induced by the volume of chemotherapy solution in patients treated with hyperthermic intraperitoneal mitomycin C , 2006, Cancer Chemotherapy and Pharmacology.

[28]  G. Griffiths,et al.  Phagocytosis: latex leads the way. , 2003, Current opinion in cell biology.

[29]  G. Sen,et al.  Double-stranded RNA Signaling by Toll-like Receptor 3 Requires Specific Tyrosine Residues in Its Cytoplasmic Domain* , 2003, The Journal of Biological Chemistry.

[30]  Roger E Bumgarner,et al.  A Comprehensive View of Regulation of Gene Expression by Double-stranded RNA-mediated Cell Signaling* , 2001, The Journal of Biological Chemistry.

[31]  B. Williams,et al.  Identification of genes differentially regulated by interferon α, β, or γ using oligonucleotide arrays , 1998 .

[32]  A. Fire,et al.  Potent and specific genetic interference by double-stranded RNA in Caenorhabditis elegans , 1998, Nature.

[33]  H. Harashima,et al.  Synergistic Effect Between Size and Cholesterol Content in the Enhanced Hepatic Uptake Clearance of Liposomes Through Complement Activation in Rats , 1996, Pharmaceutical Research.

[34]  Hideyoshi Harashima,et al.  Enhanced Hepatic Uptake of Liposomes Through Complement Activation Depending on the Size of Liposomes , 1994, Pharmaceutical Research.

[35]  N. Minakawa,et al.  The systemic administration of an anti-miRNA oligonucleotide encapsulated pH-sensitive liposome results in reduced level of hepatic microRNA-122 in mice. , 2014, Journal of controlled release : official journal of the Controlled Release Society.

[36]  E. Wisse,et al.  The role of liver sinusoidal cells in hepatocyte-directed gene transfer. , 2010, The American journal of pathology.

[37]  E. Wisse,et al.  The size of endothelial fenestrae in human liver sinusoids: implications for hepatocyte-directed gene transfer , 2008, Gene Therapy.

[38]  B. Williams,et al.  Identification of genes differentially regulated by interferon alpha, beta, or gamma using oligonucleotide arrays. , 1998, Proceedings of the National Academy of Sciences of the United States of America.

[39]  T. Honda,et al.  Systemic Leukocyte-Directed siRNA Delivery Revealing Cyclin D 1 as an Anti-Inflammatory Target , 2022 .